marginally significantP=0.05
In patients who underwent PCRT, the difference in mean cancer-specific survival between the LE and TME groups was marginally significant (84.6±5.4 months vs. 100.5±5.8 months, P=0.05), which is likely because the mean follow-up period was approximately 10 months longer in the TME than in the LE group.